Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Arioglu

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
The New England Journal of Medicine|September 24, 1998
Cushing's syndrome caused by corticotropin secretion by pulmonary tumorletsE Arioglu, J Doppman, M Gomes, et al.
The Journal of Clinical Endocrinology and Metabolism|November 4, 2000
Natural history of a proinsulin-secreting insulinoma: from symptomatic hypoglycemia to clinical diabetesE Arioglu, N A Gottlieb, C A Koch, et al.
The Journal of Clinical Investigation|November 22, 2000
Adipose tissue is required for the antidiabetic, but not for the hypolipidemic, effect of thiazolidinedionesL Chao, B Marcus-Samuels, M M Mason, et al.
American Journal of Human Genetics|March 31, 2000
Mutational and haplotype analyses of families with familial partial lipodystrophy (Dunnigan variety) reveal recurrent missense mutations in the globular C-terminal domain of lamin A/CR A Speckman, A Garg, F Du, et al.
The Netherlands Journal of Medicine|August 12, 2005
Anti-inflammatory effects of troglitazone in nondiabetic obese subjects independent of changes in insulin sensitivityL J H van Tits, E Arioglu-Oral, C G J Sweep, et al.
The Journal of Clinical Endocrinology and Metabolism|September 16, 1999
A gene for congenital generalized lipodystrophy maps to human chromosome 9q34A Garg, R Wilson, R Barnes, et al.
Annals of Internal Medicine|August 6, 2000
Efficacy and safety of troglitazone in the treatment of lipodystrophy syndromesE Arioglu, J Duncan-Morin, N Sebring, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
The New England Journal of Medicine|September 24, 1998
Cushing's syndrome caused by corticotropin secretion by pulmonary tumorletsE Arioglu, J Doppman, M Gomes, et al.
The Journal of Clinical Endocrinology and Metabolism|November 4, 2000
Natural history of a proinsulin-secreting insulinoma: from symptomatic hypoglycemia to clinical diabetesE Arioglu, N A Gottlieb, C A Koch, et al.
The Journal of Clinical Investigation|November 22, 2000
Adipose tissue is required for the antidiabetic, but not for the hypolipidemic, effect of thiazolidinedionesL Chao, B Marcus-Samuels, M M Mason, et al.
American Journal of Human Genetics|March 31, 2000
Mutational and haplotype analyses of families with familial partial lipodystrophy (Dunnigan variety) reveal recurrent missense mutations in the globular C-terminal domain of lamin A/CR A Speckman, A Garg, F Du, et al.
The Netherlands Journal of Medicine|August 12, 2005
Anti-inflammatory effects of troglitazone in nondiabetic obese subjects independent of changes in insulin sensitivityL J H van Tits, E Arioglu-Oral, C G J Sweep, et al.
The Journal of Clinical Endocrinology and Metabolism|September 16, 1999
A gene for congenital generalized lipodystrophy maps to human chromosome 9q34A Garg, R Wilson, R Barnes, et al.
Annals of Internal Medicine|August 6, 2000
Efficacy and safety of troglitazone in the treatment of lipodystrophy syndromesE Arioglu, J Duncan-Morin, N Sebring, et al.
Pageof 2